Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Establishment Labs Holdings Inc. (ESTA) Guidance & Earnings Results

On 2026-08-06 Establishment Labs Holdings Inc. raised guidance: "FY26 revenue raised to $269-271M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ESTAEstablishment Labs Holdings Inc.Follow ESTA — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
1.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Aug 26RaisedFY26 revenue raised to $269-271M from $266.5-268.5M · full year
6 May 26RaisedFY2026 revenue $266.5-268.5M (from $264-266M); minimally invasive >$35M (from $30M) · full year
24 Feb 26Raised2026 revenue guidance $264-266M (+25-26% YoY); 2027 revenue growth projected at least 25%.
12 Jan 26RaisedFY2025 revenue $210.5-211.5M, 27% growth
5 Nov 25RaisedFY2025 revenue guidance raised to >$210M from $208-212M · full year
7 Aug 25RaisedFY2025 revenue guidance raised to $208-$212M from $205-$210M (25%-28% YoY growth); at least $40M US Motiva revenue expected; positive EBITDA target for 2025 reiterated; cash flow positive expected in 2026 · full year

Establishment Labs Holdings Inc. — questions

What guidance did Establishment Labs Holdings Inc. give?
On 2026-08-06: "FY26 revenue raised to $269-271M from $266.5-268.5M"
When does Establishment Labs Holdings Inc. report earnings?
Establishment Labs Holdings Inc.'s next earnings report is expected on 2026-10-29.

Every figure on this page comes from Establishment Labs Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.